The new doors AI and machine learning are opening to scientists undoubtedly will invite weighty ethical and moral questions as well. But the dawn of a new way of manipulating life's building blocks ...

Researchers from the School of Engineering and Applied Science and the Perelman School of Medicine, along with the Children's ...

This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.

An interdisciplinary research team from Leipzig University and the Saxon AI center ScaDS.AI has developed a novel approach ...

Latent Labs hopes to take computational biology one step further. The company is developing foundation AI models that don’t ...

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.

Researchers from Heidelberg University, Heidelberg University Hospital (UKHD) and Heidelberg Institute for Theoretical ...

Vimentin is a type III intermediate filament (IF) protein normally expressed in cells that develop into connective tissue, ...

For decades, scientists across the globe have investigated methods to accurately measure drug permeability across the blood-brain barrier, a compact layer of cells that protect the brain from ...

Changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth by increasing cancer stemness in an oestrogen independent manner.